UniProt ID | GEMI4_HUMAN | |
---|---|---|
UniProt AC | P57678 | |
Protein Name | Gem-associated protein 4 | |
Gene Name | GEMIN4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1058 | |
Subcellular Localization | Cytoplasm. Nucleus. Nucleus, nucleolus. Nucleus, gem. Localized in subnuclear structures next to coiled bodies, called gems, which are highly enriched in spliceosomal snRNPs and in the nucleolus. | |
Protein Description | The SMN complex plays a catalyst role in the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Thereby, plays an important role in the splicing of cellular pre-mRNAs. Most spliceosomal snRNPs contain a common set of Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG that assemble in a heptameric protein ring on the Sm site of the small nuclear RNA to form the core snRNP. In the cytosol, the Sm proteins SNRPD1, SNRPD2, SNRPE, SNRPF and SNRPG are trapped in an inactive 6S pICln-Sm complex by the chaperone CLNS1A that controls the assembly of the core snRNP. Dissociation by the SMN complex of CLNS1A from the trapped Sm proteins and their transfer to an SMN-Sm complex triggers the assembly of core snRNPs and their transport to the nucleus.. | |
Protein Sequence | MDLGPLNICEEMTILHGGFLLAEQLFHPKALAELTKSDWERVGRPIVEALREISSAAAHSQPFAWKKKALIIIWAKVLQPHPVTPSDTETRWQEDLFFSVGNMIPTINHTILFELLKSLEASGLFIQLLMALPTTICHAELERFLEHVTVDTSAEDVAFFLDVWWEVMKHKGHPQDPLLSQFSAMAHKYLPALDEFPHPPKRLRSDPDACPTMPLLAMLLRGLTQIQSRILGPGRKCCALANLADMLTVFALTEDDPQEVSATVYLDKLATVISVWNSDTQNPYHQQALAEKVKEAERDVSLTSLAKLPSETIFVGCEFLHHLLREWGEELQAVLRSSQGTSYDSYRLCDSLTSFSQNATLYLNRTSLSKEDRQVVSELAECVRDFLRKTSTVLKNRALEDITASIAMAVIQQKMDRHMEVCYIFASEKKWAFSDEWVACLGSNRALFRQPDLVLRLLETVIDVSTADRAIPESQIRQVIHLILECYADLSLPGKNKVLAGILRSWGRKGLSEKLLAYVEGFQEDLNTTFNQLTQSASEQGLAKAVASVARLVIVHPEVTVKKMCSLAVVNLGTHKFLAQILTAFPALRFVEEQGPNSSATFMVSCLKETVWMKFSTPKEEKQFLELLNCLMSPVKPQGIPVAALLEPDEVLKEFVLPFLRLDVEEVDLSLRIFIQTLEANACREEYWLQTCSPFPLLFSLCQLLDRFSKYWQLPKEKRCLSLDRKDLAIHILELLCEIVSANAETFSPDVWIKSLSWLHRKLEQLDWTVGLRLKSFFEGHFKCEVPATLFEICKLSEDEWTSQAHPGYGAGTGLLAWMECCCVSSGISERMLSLLVVDVGNPEEVRLFSKGFLVALVQVMPWCSPQEWQRLHQLTRRLLEKQLLHVPYSLEYIQFVPLLNLKPFAQELQLSVLFLRTFQFLCSHSCRDWLPLEGWNHVVKLLCGSLTRLLDSVRAIQAAGPWVQGPEQDLTQEALFVYTQVFCHALHIMAMLHPEVCEPLYVLALETLTCYETLSKTNPSVSSLLQRAHEQRFLKSIAEGIGPEERRQTLLQKMSSF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDLGPLNI -------CCCCCCCC | 42.07 | 19413330 | |
13 | Phosphorylation | LNICEEMTILHGGFL CCCCCCCHHCCCCCH | 24.54 | 26503514 | |
36 | Ubiquitination | KALAELTKSDWERVG HHHHHHCHHHHHHHC | 60.07 | 21890473 | |
66 | Acetylation | HSQPFAWKKKALIII HCCCCCCHHHEEEEE | 40.75 | 26051181 | |
66 | Ubiquitination | HSQPFAWKKKALIII HCCCCCCHHHEEEEE | 40.75 | 21890473 | |
68 | Acetylation | QPFAWKKKALIIIWA CCCCCHHHEEEEEEE | 44.70 | 21466224 | |
84 | Phosphorylation | VLQPHPVTPSDTETR HHCCCCCCCCCCCCC | 22.86 | 29255136 | |
86 | Phosphorylation | QPHPVTPSDTETRWQ CCCCCCCCCCCCCCC | 48.04 | 29255136 | |
88 | Phosphorylation | HPVTPSDTETRWQED CCCCCCCCCCCCCHH | 43.52 | 29255136 | |
90 | Phosphorylation | VTPSDTETRWQEDLF CCCCCCCCCCCHHCE | 39.02 | 29255136 | |
188 | Ubiquitination | QFSAMAHKYLPALDE HHHHHHHHHHHHHCC | 38.66 | - | |
201 | Ubiquitination | DEFPHPPKRLRSDPD CCCCCCCCCCCCCCC | 69.39 | 21906983 | |
205 | Phosphorylation | HPPKRLRSDPDACPT CCCCCCCCCCCCCCH | 59.07 | 22617229 | |
210 | Glutathionylation | LRSDPDACPTMPLLA CCCCCCCCCHHHHHH | 3.62 | 22555962 | |
212 | Phosphorylation | SDPDACPTMPLLAML CCCCCCCHHHHHHHH | 31.16 | - | |
292 | Acetylation | HQQALAEKVKEAERD HHHHHHHHHHHHHHC | 53.66 | 26051181 | |
292 | Ubiquitination | HQQALAEKVKEAERD HHHHHHHHHHHHHHC | 53.66 | 21890473 | |
294 | Ubiquitination | QALAEKVKEAERDVS HHHHHHHHHHHHCCC | 63.37 | - | |
301 | Phosphorylation | KEAERDVSLTSLAKL HHHHHCCCHHHHCCC | 30.16 | 21815630 | |
303 | Phosphorylation | AERDVSLTSLAKLPS HHHCCCHHHHCCCCC | 17.75 | 23312004 | |
304 | Phosphorylation | ERDVSLTSLAKLPSE HHCCCHHHHCCCCCC | 31.46 | 20873877 | |
341 | Phosphorylation | VLRSSQGTSYDSYRL HHHHCCCCCCCHHHC | 19.24 | 20860994 | |
343 | Phosphorylation | RSSQGTSYDSYRLCD HHCCCCCCCHHHCHH | 14.56 | 20860994 | |
345 | Phosphorylation | SQGTSYDSYRLCDSL CCCCCCCHHHCHHHC | 12.15 | 20860994 | |
346 | Phosphorylation | QGTSYDSYRLCDSLT CCCCCCHHHCHHHCC | 12.52 | 20860994 | |
351 | Phosphorylation | DSYRLCDSLTSFSQN CHHHCHHHCCHHCCC | 32.33 | 30622161 | |
353 | Phosphorylation | YRLCDSLTSFSQNAT HHCHHHCCHHCCCCE | 31.51 | 30622161 | |
354 | Phosphorylation | RLCDSLTSFSQNATL HCHHHCCHHCCCCEE | 28.35 | 25693802 | |
370 | Ubiquitination | LNRTSLSKEDRQVVS ECCCCCCHHHHHHHH | 69.77 | 21906983 | |
377 | Phosphorylation | KEDRQVVSELAECVR HHHHHHHHHHHHHHH | 28.21 | 26074081 | |
389 | Ubiquitination | CVRDFLRKTSTVLKN HHHHHHHHHHHHHHH | 49.31 | - | |
390 | Phosphorylation | VRDFLRKTSTVLKNR HHHHHHHHHHHHHHH | 24.17 | 26074081 | |
391 | Phosphorylation | RDFLRKTSTVLKNRA HHHHHHHHHHHHHHH | 21.39 | 26074081 | |
392 | Phosphorylation | DFLRKTSTVLKNRAL HHHHHHHHHHHHHHH | 34.78 | 26074081 | |
395 | 2-Hydroxyisobutyrylation | RKTSTVLKNRALEDI HHHHHHHHHHHHHHH | 39.80 | - | |
395 | Ubiquitination | RKTSTVLKNRALEDI HHHHHHHHHHHHHHH | 39.80 | - | |
414 | Ubiquitination | AMAVIQQKMDRHMEV HHHHHHHHHHHHCEE | 26.79 | - | |
429 | Ubiquitination | CYIFASEKKWAFSDE EEEEECCCCCCCCCC | 51.63 | - | |
430 | Ubiquitination | YIFASEKKWAFSDEW EEEECCCCCCCCCCH | 39.44 | - | |
497 | Ubiquitination | LSLPGKNKVLAGILR CCCCCCCHHHHHHHH | 41.95 | - | |
536 | Phosphorylation | TFNQLTQSASEQGLA HHHHHHHHHHHHHHH | 28.64 | 30622161 | |
538 | Phosphorylation | NQLTQSASEQGLAKA HHHHHHHHHHHHHHH | 35.38 | 30622161 | |
619 | Ubiquitination | WMKFSTPKEEKQFLE HHHCCCCHHHHHHHH | 77.81 | - | |
670 | Phosphorylation | DVEEVDLSLRIFIQT CHHHHHHHHHHHHHH | 15.90 | 24719451 | |
716 | Ubiquitination | SKYWQLPKEKRCLSL HHHCCCCHHHCCCCC | 81.89 | - | |
775 | Ubiquitination | WTVGLRLKSFFEGHF CHHHHHHHHHHCCCC | 38.49 | - | |
850 | Phosphorylation | PEEVRLFSKGFLVAL HHHHHHHCCHHHHHH | 36.14 | 24719451 | |
1018 | Phosphorylation | CYETLSKTNPSVSSL HHHHHHCCCCCHHHH | 49.32 | 20068231 | |
1021 | Phosphorylation | TLSKTNPSVSSLLQR HHHCCCCCHHHHHHH | 36.38 | 30622161 | |
1023 | Phosphorylation | SKTNPSVSSLLQRAH HCCCCCHHHHHHHHH | 21.43 | 30622161 | |
1024 | Phosphorylation | KTNPSVSSLLQRAHE CCCCCHHHHHHHHHH | 30.83 | 20068231 | |
1036 | Ubiquitination | AHEQRFLKSIAEGIG HHHHHHHHHHHHCCC | 36.78 | - | |
1036 | Acetylation | AHEQRFLKSIAEGIG HHHHHHHHHHHHCCC | 36.78 | 26051181 | |
1050 | Phosphorylation | GPEERRQTLLQKMSS CHHHHHHHHHHHHHC | 27.85 | - | |
1054 | Ubiquitination | RRQTLLQKMSSF--- HHHHHHHHHHCC--- | 40.49 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GEMI4_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GEMI4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GEMI4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
DDX20_HUMAN | DDX20 | physical | 12668731 | |
PP4C_HUMAN | PPP4C | physical | 12668731 | |
PP4R2_HUMAN | PPP4R2 | physical | 12668731 | |
LEG1_HUMAN | LGALS1 | physical | 11522829 | |
LEG3_HUMAN | LGALS3 | physical | 11522829 | |
DDX20_HUMAN | DDX20 | physical | 10725331 | |
AGO2_HUMAN | AGO2 | physical | 11914277 | |
CACO2_HUMAN | CALCOCO2 | physical | 12869526 | |
CACO2_HUMAN | CALCOCO2 | physical | 23143396 | |
HDA11_HUMAN | HDAC11 | physical | 23752268 | |
SMN_HUMAN | SMN1 | physical | 23752268 | |
DDX20_HUMAN | DDX20 | physical | 23752268 | |
GEMI4_HUMAN | GEMIN4 | physical | 23752268 | |
DICER_HUMAN | DICER1 | physical | 23752268 | |
MORC4_HUMAN | MORC4 | physical | 21988832 | |
SQSTM_HUMAN | SQSTM1 | physical | 21988832 | |
SPY1_HUMAN | SPRY1 | physical | 21988832 | |
PIAS3_HUMAN | PIAS3 | physical | 21988832 | |
SRRT_HUMAN | SRRT | physical | 21988832 | |
GLYR1_HUMAN | GLYR1 | physical | 21988832 | |
NUFP1_HUMAN | NUFIP1 | physical | 26275778 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-205, AND MASSSPECTROMETRY. |